Archives
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
- 2021-12
- 2021-11
- 2021-10
- 2021-09
- 2021-08
- 2021-07
- 2021-06
- 2021-05
- 2021-04
- 2021-03
- 2021-02
- 2021-01
- 2020-12
- 2020-11
- 2020-10
- 2020-09
- 2020-08
- 2020-07
- 2020-06
- 2020-05
- 2020-04
- 2020-03
- 2020-02
- 2020-01
- 2019-12
- 2019-11
- 2019-10
- 2019-09
- 2019-08
- 2019-07
- 2019-06
- 2019-05
- 2019-04
- 2018-11
- 2018-10
- 2018-07
-
The termini of the substrate recognition and
2020-08-07

The termini of the substrate recognition and catalytic modules are anchored to opposite sides of the scaffold so that they face each other. Within the substrate recognition module, the coactivators CDC20 and CDH1 have three domains: intrinsically disordered N- and C-terminal regions containing so-ca
-
A939572 synthesis br Results br Discussion Taking advantage
2020-08-07

Results Discussion Taking advantage of the highly specific protein–protein interactions among cognate A939572 synthesis that mediate SUMO conjugation to substrates, we have developed a novel strategy for achieving inhibition of SUMO conjugation in vivo based on disruption of SUMO E1–E2 intera
-
One of the important steroid degrading enzymes is ketosteroi
2020-08-07

One of the important steroid-degrading enzymes is 3-ketosteroid Δ1-dehydrogenase (3-oxosteroid 1-dehydrogenase; 4-ene-3-oxosteroid:(acceptor)-1-ene-oxidoreductase; EC 1.3.99.4; Δ1-KSTD). In bacteria, the enzyme is crucial for activating the steroid nucleus for degradation, under both aerobic and Cy5
-
Noteworthy glycation resulted in significant change of synuc
2020-08-07

Noteworthy, glycation resulted in significant change of α-synuclein region involved in the binding. Thus, native α-synuclein without modifications interacted with GAPDH generally via C-terminal region (Fig. 3B, top panel) enriched with negatively charged residues (see the band below the bar chart, n
-
A striking finding was that hypertension or diabetes
2020-08-06

A striking finding was that hypertension or diabetes increased ETRA, ETRB, ET-1 and ET-2 Tempol in retina and RPE/choroid. These levels were not further increased by the combination of hypertension and diabetes indicating that either condition may have induced maximal stimulation of the ET system a
-
Sitafloxacin Hydrate What would be the possible
2020-08-06

What would be the possible off-target effects of enhancing Ndfip1 to control T cell responses? Increasing Ndfip1 activity could limit cytokine production in macrophages, where it has been shown to function in mouse BMDMs to degrade Tak1 and downregulate NFκB signaling [108]. Whether Ndfip1 regulates
-
Many important regulatory proteins in innate immune pathways
2020-08-06

Many important regulatory proteins in innate immune pathways may be modified by ubiquitin [[11], [12], [13]]. On the other hand, Many de-ubiquitination (DUB) proteins may affect immunity. We have found that the papain-like proteases (PLPs) encoded by coronavirus (CoV) reduce the ubiquitinated modifi
-
Following DEX exposure the levels of CYP A protein and
2020-08-06

Following DEX exposure, the levels of CYP1A1 protein and activity remained unchanged, as seen in our previous in vitro study (Burkina et al., 2013). Dasmahapatra and Lee (1993) reported that 3.9μgL−1 DEX, similar to our highest tested concentration, did not change CYP1A1 protein content. An increase
-
This study also found that CuE
2020-08-06

This study also found that CuE significantly inhibited P-gp activity with no effect on its expression. Since CuE presented potent inhibition on both CYP3A and P-gp activities in vitro, it may increase the exposed quantity of co-administered drugs in the body and cause drug-induced toxicity. To clari
-
In the case of women and
2020-08-06

In the case of women and men diagnosed with APD, no increase in the IL-6 level was found as compared with the control group. However, such an increase, which was double, was observed both in the group of women and men with APD and PTSD versus the group of women and men suffering from APD alone. This
-
Our study using real time confocal microscopy
2020-08-06

Our study using real-time confocal microscopy in live ML 239 australia provides the first evidence that the human CRF2(a) receptor activated by UCN2 or UCN3 rapidly and strongly recruits GFP-labeled βarrestin2 to the plasma membrane where βarrestin2 proteins colocalize with CRF2(a) receptor protein
-
Demethoxycurcumin Atomic structures of mammalian and fungal
2020-08-06

Atomic structures of mammalian and fungal CRM1, alone and in complex with different binding partners, have revealed that CRM1 undergoes multiple conformational changes as it shuttles between the nucleus, where cooperative assembly of the CRM1/Ran/cargo complex occurs, and the cytosol, where the comp
-
This study focuses on mechanisms of reciprocity between
2020-08-06

This study focuses on mechanisms of reciprocity between DGTS and PC in fungi during Pi starvation. We report changes in expression of the BTA1 gene and two PC biosynthesis genes during phosphate starvation of F. velutipes culture. We describe the deduced amino GSK621 sequence and genomic structure
-
br Group IVA PLA also
2020-08-06

Group IVA PLA2, also known as cytosolic phospholipase A2α (cPLA2α), is long known to exhibit marked preference for phospholipid substrates containing AA at the sn-2 position. The aromatic residues of cPLA2α interact with the double bonds of AA, making the enzyme selective for this fatty acid. cPLA
-
The aim of the current project was to
2020-08-05

The aim of the current project was to establish an E. coli based expression system to produce high amounts of recombinant Lys-C. Furthermore, the development of an optimized refolding process for Lys-C using the separately recombinant produced N-terminal pro-peptide of Lys-C in the refolding assay w
16167 records 807/1078 page Previous Next First page 上5页 806807808809810 下5页 Last page